Resveratrol induces immunogenic cell death by increasing CRT and HMGB1 expression in ovarian cancer cells, reducing tumor volume, suppressing TGF-β, and boosting IL-12 and IFN-γ levels [116,120,121]. The gene discussed is HMGB1; the disease is neoplasm.